Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting
Status: Enrolling
Updated:  4/7/2016
University of Virginia
mi
from
Charlottesville, VA
Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting
Early Feasibility Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAS) in the Outpatient Setting
Status: Enrolling
Updated: 4/7/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Chromium and Insulin Action
Effect of Chromium Picolinate on Metabolic and Physiologic Parameters in Type 2 Diabetes
Status: Enrolling
Updated:  4/7/2016
University of Vermont
mi
from
Burlington, VT
Chromium and Insulin Action
Effect of Chromium Picolinate on Metabolic and Physiologic Parameters in Type 2 Diabetes
Status: Enrolling
Updated: 4/7/2016
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes
Chromium and Insulin Action
Status: Enrolling
Updated:  4/7/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Effect of Chromium Picolinate on Insulin Sensitivity in Type 2 Diabetes
Chromium and Insulin Action
Status: Enrolling
Updated: 4/7/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Boosting Emotions & Happiness in Outpatients Living With Diabetes
A Positive Psychology Program for Patients With Type 2 Diabetes: A Pilot Study
Status: Enrolling
Updated:  4/7/2016
Massachusetts General Hospital
mi
from
Boston, MA
Boosting Emotions & Happiness in Outpatients Living With Diabetes
A Positive Psychology Program for Patients With Type 2 Diabetes: A Pilot Study
Status: Enrolling
Updated: 4/7/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  4/12/2016
Emory University Hospital
mi
from
Atlanta, GA
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 4/12/2016
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  4/12/2016
Grady Memorial Hospital
mi
from
Atlanta, GA
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 4/12/2016
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  4/12/2016
University of Michigan
mi
from
Ann Arbor, MI
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 4/12/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  4/12/2016
Ohio State University
mi
from
Columbus, OH
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 4/12/2016
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated:  4/12/2016
Temple University
mi
from
Philadelphia, PA
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Randomized Controlled Trial on the Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Status: Enrolling
Updated: 4/12/2016
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Matrix Metalloproteinases and Diabetic Nephropathy
Matrix Metalloproteinases and Diabetic Nephropathy
Status: Enrolling
Updated:  4/12/2016
Arkansas Children's Hospital/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Matrix Metalloproteinases and Diabetic Nephropathy
Matrix Metalloproteinases and Diabetic Nephropathy
Status: Enrolling
Updated: 4/12/2016
Arkansas Children's Hospital/University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus
Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  4/13/2016
Stanford University
mi
from
Stanford, CA
Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus
Neuropsychological and Neuroanatomical Studies of Young Children With and Without Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 4/13/2016
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
Effect of the Insupatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
Status: Enrolling
Updated:  4/13/2016
Yale University School of Medicine
mi
from
New Haven, CT
Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
Effect of the Insupatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
Status: Enrolling
Updated: 4/13/2016
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
The Effects of High and Low Blood Glucose Values on the Brain in Children With Type 1 Diabetes Mellitus
Neurocognitive and Neuroanatomical Studies in Young Children With Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  4/13/2016
Stanford University School of Medicine
mi
from
Stanford, CA
The Effects of High and Low Blood Glucose Values on the Brain in Children With Type 1 Diabetes Mellitus
Neurocognitive and Neuroanatomical Studies in Young Children With Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 4/13/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tucson, AZ
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Chino, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Fresno, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
National City, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
San Francisco, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Boulder, CO
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
DeLand, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Fort Meyers, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Miami, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Orlando, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tampa, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Idaho Falls, ID
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Meridan, ID
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Meridan, ID
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Lexington, KY
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Boston, MA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Kansas City, MO
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Tulsa, OK
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Greer, SC
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Dallas, TX
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Houston, TX
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated:  4/18/2016
Clinical Research Facility
mi
from
Norfolk, VA
Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
A Phase 2b Repeat Dosing Clinical Trial of SB-509 in Subjects With Moderately Severe Diabetic Neuropathy
Status: Enrolling
Updated: 4/18/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Spanish Diabetes Self-Management Program
Spanish Diabetes Self-Management Program
Status: Enrolling
Updated:  4/18/2016
Stanford Patient Education Research Center
mi
from
Palo Alto, CA
Spanish Diabetes Self-Management Program
Spanish Diabetes Self-Management Program
Status: Enrolling
Updated: 4/18/2016
Stanford Patient Education Research Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Activator and Type II Diabetics
Effect of Activator Methods Technique on Lowering A1c Levels in Type II Diabetics
Status: Enrolling
Updated:  4/19/2016
Life University
mi
from
Marietta, GA
Activator and Type II Diabetics
Effect of Activator Methods Technique on Lowering A1c Levels in Type II Diabetics
Status: Enrolling
Updated: 4/19/2016
Life University
mi
from
Marietta, GA
Click here to add this to my saved trials
Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
Status: Enrolling
Updated:  4/20/2016
Iowa City VA Health Care System, Iowa City, IA
mi
from
Iowa City, IA
Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
Retinal Vessel Measurements as Clinically Useful Predictors in Veterans
Status: Enrolling
Updated: 4/20/2016
Iowa City VA Health Care System, Iowa City, IA
mi
from
Iowa City, IA
Click here to add this to my saved trials
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Status: Enrolling
Updated:  4/20/2016
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
Status: Enrolling
Updated: 4/20/2016
Ophthalmic Consultants of Long Island
mi
from
Lynbrook, NY
Click here to add this to my saved trials
Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp
Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS) and Technosphere® Insulin Inhalation System From MannnKind Corp.
Status: Enrolling
Updated:  4/20/2016
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp
Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS) and Technosphere® Insulin Inhalation System From MannnKind Corp.
Status: Enrolling
Updated: 4/20/2016
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Outpatient Control-to-Range: System and Monitoring Testing
Systems Approach to Closed-Loop Control of Type 1 Diabetes at Home
Status: Enrolling
Updated:  4/20/2016
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Outpatient Control-to-Range: System and Monitoring Testing
Systems Approach to Closed-Loop Control of Type 1 Diabetes at Home
Status: Enrolling
Updated: 4/20/2016
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Click here to add this to my saved trials